A newly enacted Michigan law requires that: “A recipient of a COVID-19 vaccine … shall be provided with information or informed if and in what manner the development of the vaccine utilized aborted fetal tissue or human embryonic stem cell derivation lines.” ICAN sent a letter to the Michigan Department of Health and Human Services on May 4, 2021 seeking a copy of the document(s) by which COVID-19 vaccine recipients are being provided this information.
The development of each of the three current COVID-19 vaccines currently in use involved aborted fetal tissue or human embryonic stem cell derivation lines:
- Johnson & Johnson/Janssen: Fetal cell cultures are used to produce and manufacture the J&J COVID-19 vaccine and the final formulation of this vaccine includes residual amounts of the fetal host cell proteins3 (≤0.15 mcg) and/or host cell DNA4 (≤3 ng).
- Pfizer/BioNTech: The HEK-29c5 abortion-related cell line was used in research related to the development of the Pfizer COVID-19 vaccine.
- Moderna/NIAID: Aborted fetal cell lines were used in both the development and testing of Moderna's6 COVID-19 vaccine.
2https://www.icandecide.org/wp-content/uploads/2021/05/Michigan-law-re-information-about-aborted-fetal-cell_2021_05_04.pdf
3https://www.fda.gov/media/146303/download
4https://www.fda.gov/media/146304/download
5https://www.biorxiv.org/content/10.1101/2020.09.08.280818v1.full.pdf
6https://www.nature.com/articles/s41586-020-2622-0.pdf
Informed Consent Action Network, 2025 Guadalupe Street Suite 260 Austin, Texas 78705